The increasing demand for specific immunological research and therapeutic design has spurred significant advances in recombinant cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently generated using multiple expression platforms, including prokaryotic hosts, higher cell lines, and baculovirus